How much does a box of Entrectinib cost?
Entrectinib (Entrectinib) is a multi-target tyrosine kinase inhibitor that mainly acts on fusion genes such as NTRK, ROS1 and ALK. It is often used to treat non-small cell lung cancer and other refractory solid tumors carrying these gene fusions. Unlike traditional chemotherapy, entrectinib can directly block abnormally activated signaling pathways, thereby effectively inhibiting tumor growth and showing obvious advantages in controlling brain metastasis, which makes it occupy an important position in the landscape of precision medicine.
In terms of clinical application, the advantage of entrectinib is its wider coverage. It is not only suitable for lung cancer patients, but also for rare tumor patients with NTRK gene fusion, which gives more tumor patients new hope. At the same time, the convenience of oral administration improves patient compliance, making it one of the ideal options for long-term treatment.
Regarding price, entrectinib has been officially launched in the country and has been included in medical insurance. Taking 90 tablets of 200mg as an example, the cost after medical insurance reimbursement still needs to exceed 20,000 yuan, which is still a high expense for many patients. However, compared with the price before reimbursement, the financial burden has been significantly reduced. If we look at overseas markets, the price of the European original research version is higher, reaching more than 40,000 yuan per box, and the price will fluctuate due to exchange rate fluctuations.
In terms of generic drugs, the version produced by Lucius Pharmaceuticals in Laos has attracted attention because of its affordable price. Its 200mg generic drug only costs more than 1,000 yuan per box, and its ingredients are basically the same as the original drug, providing an alternative for patients with limited financial conditions. However, when purchasing generic drugs, you must go through formal channels to ensure the source and quality of the drugs.
Reference materials:https://www.roche.com/products/rozlytrek
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)